ASPREE shows no stroke benefit for low dose aspirin and some risk of bleeding

Low-dose aspirin should not be used for primary prevention in older people as it has no benefit and increases the risk of major bleeding events, an Australian RCT has shown. Among the many outcomes assessed in the five-year Aspirin in Reducing Events in the Elderly (ASPREE) trial, Australian researchers showed that low-dose aspirin did not reduce ...

Already a member?

Login to keep reading.

© 2021 the limbic